CN101113460A - Recombined rhabdovirus AcBac delt CC-GP41 and constructing method thereof - Google Patents

Recombined rhabdovirus AcBac delt CC-GP41 and constructing method thereof Download PDF

Info

Publication number
CN101113460A
CN101113460A CNA2007100526290A CN200710052629A CN101113460A CN 101113460 A CN101113460 A CN 101113460A CN A2007100526290 A CNA2007100526290 A CN A2007100526290A CN 200710052629 A CN200710052629 A CN 200710052629A CN 101113460 A CN101113460 A CN 101113460A
Authority
CN
China
Prior art keywords
bac
acbac
recombinant baculovirus
baculovirus
pfastbachtc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2007100526290A
Other languages
Chinese (zh)
Other versions
CN101113460B (en
Inventor
苏正元
李娟�
王华林
邓菲
胡志红
袁丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wuhan Institute of Virology of CAS
Original Assignee
Wuhan Institute of Virology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan Institute of Virology of CAS filed Critical Wuhan Institute of Virology of CAS
Priority to CN2007100526290A priority Critical patent/CN101113460B/en
Publication of CN101113460A publication Critical patent/CN101113460A/en
Application granted granted Critical
Publication of CN101113460B publication Critical patent/CN101113460B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention provides a recombinant baculovirus AcBacDeltaCC-GP41 and an establishment method thereof and relates to the technical field of biological engineering technique and pharmacological. The recombinant baculovirus is CCTCC NO.V200702 and the establishment method comprises the steps: the expression system of Bac-to-Bac baculovirus developed by INVITROGEN Company is used, an AcMNPV baculovirus carrier is selected, then double-deletion shuttle carrier Ac-bacDeltaCC is obtained through a reformation of an AcMNPV shuttle carrier and last the recombinant baculovirus AcBacDeltaCC-GP41 is obtained by using insect cell expression system. The invention has the advantages that the virus is the protein recombinant virus which can high effectively express HIV-1 and has the full length of GP41 and the structure and function thereof are close to natural protein and beneficial for studying natural conformation of GP41 and paves the solid foundation for fully explaining mechanism of HIV-1 entering cells and the immune diagnose and vaccine development based on GP41 and the prevention and curing of AIDS.

Description

Recombinant baculovirus AcBac Δ CC-GP41 and construction process thereof
Technical field
The present invention relates to biotechnology and medical technical field, particularly relate to a kind of recombinant baculovirus that can efficiently express HIV-1 envelope glycoprotein GP41.The invention still further relates to the construction process of this recombinant baculovirus.
Background technology
The rhabdovirus expression vector that is most widely used at present is a commercial baculovirus Bac-to-Bac system, and its most frequently used baculovirus vector is an Autographa californica multicapsid nucleopolyhedrosisvirus multinuclear capsid nuclear polyhedrosis virus (AcMNPV).The Bac-to-Bac baculovirus expression system mainly is made up of donor plasmid, shuttle vectors bacmid, insect cell, because this method is quick and easy, the screening cycle of whole recombinant virus is 7~10 days, and can step sizing, simultaneously, donor plasmid can be constructed more restriction enzyme site and transform, and is beneficial to the insertion of foreign gene.
I type human immunodeficiency virus (HIV-1) is the main pathogen that causes China's AIDS (AIDS).Enter in the early stage process of target cell at the HIV-1 infection host, its membrane glycoprotein (GP120 and GP41) plays key effect.The relative gp120 of the variation of gp41 gene fragment is comparatively conservative, wherein GP41 is the coded transmembrane protein of HIV-1 envelope protein encoding gene env, can be divided into film outskirt (ecmdomain), stride film district (transmembrane), 3 parts of cytoplasmic region (cytoplasmic domain), its major function is the fusion of mediation viromembrane and target cell membrane.GP41 has more stable antigenic determinant, and the antibody of generation is sustainable lifelong.Stride the structure of film district, cytoplasmic region and the effect details in fusion is also not fully aware of at present for some mechanism, the especially GP41 of HIV invasion cell, the GP41 native conformation is also understood fully.Clearly also need to carry out more deep research and exploration for these mechanism, and effective expression GP41 full length fragment helps the understanding to the HIV mechanism of causing a disease, develop effective way more effective, more economical, the still less antiviral of side effect, and preparation HIV vaccine.
From both at home and abroad to the research of HIV-1 envelope glycoprotein as can be known, envelope glycoprotein has sufficient development space to the research of HIV-1 medicine.Yet, make its full length fragment be difficult to effective expression because the proteic membrane property of wearing of HIV-1 glycoprotein GP41 causes toxic action to the host.Usually adopt prokaryotic expression methods such as segmentation, low temperature induction at present at GP41.As " expression of HIVgp41 gene segmentation low temperature induction " (Yuan Yuhua etc., " Chinese virusology ", 2004,19 (2), 179-181), improve the expression effect of GP41 albumen in prokaryotic system with the low temperature expression technology exactly.But the product that this article obtains is the prokaryotic expression product, thereby with native protein very big difference is arranged, and is not the expression of full length fragment, and also there are a lot of difficulties in the proteic purifying of GP41 of expressing with this method simultaneously.
International monopoly document mandate publication No. WO2005/010033 is in order to overcome the difficulty that GP41 albumen is difficult for expression on November 8th, 2006 disclosed " the GP41 polypeptide of new solvable and stable trimeric form ", and the polypeptide of the shack between the terminal spiral of the N-that has constructed a kind of modified gp41 ectodomain that has comprised HIV-1 and the C-end spiral, this polypeptide is to have sufficient hydrophilic solubility to stablize tripolymer.But this invention is not the GP41 albumen of total length, exists bigger difference with natural GP41 albumen.
Summary of the invention
The objective of the invention is: recombinant baculovirus AcBac is provided △ CC-GP41, this recombinant baculovirus can efficiently express HIV glycoprotein GP41, and the GP41 albumen of expression is full-length proteins, and its foreign protein has better antigenic activity, and the eucaryon after expressing has rhetorical function.Another object of the present invention is: recombinant baculovirus AcBac is provided △ CCThe construction process of-GP41, this method are to utilize the exploitation Bac-to-Bac of INVITROGEN company baculovirus expression system, select the AcMNPV baculovirus vector for use, obtain two disappearance shuttle vectors Ac-bac by transforming AcMNPV shuttle vectors (Ac-bacmid) △ CC, obtain recombinant baculovirus AcBac with the insect cell expression system again △ CC-GP41.The acquisition of this recombinant baculovirus helps studying the native conformation of GP41, is the mechanism that complete explanation HIV-1 enters cell, also lays a good foundation for the control based on immunodiagnosis, vaccine research and development and the acquired immune deficiency syndrome (AIDS) of GP41 simultaneously.
In order to achieve the above object, the present invention adopts following technical scheme:
Recombinant baculovirus AcBac △ CC-GP41, by China's typical culture collection center preservation, preservation date: on May 18th, 2007, preserving number: CCTCCNO.V200702.
Recombinant baculovirus AcBac △ CCThe construction process of-GP41 is: with the Bac-to-Bac baculovirus expression system of INVITROGEN company, utilize donor plasmid pFastBacHTc, gp41 is cloned on the multiple clone site of pFastBacHTc with HIV-1 membrane glycoprotein GP41 gene, (6 * his) labels merge frame to make gp41 gene order and 6 Histidines, obtain new donor plasmid pFastBacHTc-gp41, utilize the homology arm on this plasmid that its swivel base is arrived two shuttle vectors Ac-bac that lack again △ CCOn, obtain recombinant shuttle vector Ac-bac △ CC-gp41, transfection insect cell through cultivating and purifying, can obtain recombinant virus AcBac then △ CC-Gp41, i.e. CCTCCNO.V200702.
Compared with prior art, the invention has the advantages that: recombinant baculovirus AcBac of the present invention △ CC-GP41 a kind ofly can efficiently express the proteic recombinant virus of HIV-1 total length GP41, its structure and function are more near native protein, help studying the native conformation of GP41, being the mechanism that complete explanation HIV-1 enters cell, also is that the control of immunodiagnosis, vaccine research and development and acquired immune deficiency syndrome (AIDS) based on GP41 is laid a good foundation simultaneously.
Recombinant baculovirus AcBac △ CCThe construction process of-GP41 has utilized a kind of eukaryotic expression system fast and efficiently---AcMNPV Bac-to-Bac baculovirus expression system, make the structure of recombinant baculovirus simple to operate, quick, safe, efficient, the GP41 albumen of expressing is full-length proteins, and expression amount big, have the back of an expression eucaryon rhetorical function, the foreign protein of expressing has better antigenic activity, greatly facilitates the expression of transmembrane protein and follow-up purifying.
Description of drawings
Fig. 1 is recombinant baculovirus AcBac of the present invention △ CCThe donor plasmid pFastBacHTc synoptic diagram that-Gp41 selects for use.
Fig. 2 is recombinant baculovirus AcBac of the present invention △ CCThe synoptic diagram of-Gp41 structure.
Fig. 3 is recombinant baculovirus AcBac of the present invention △ CCThe synoptic diagram of-Gp41 building process.
Fig. 4 is recombinant baculovirus AcBac of the present invention △ CCThe SDS-PAGE glue of-Gp41 detects figure.
Embodiment
Recombinant baculovirus AcBac △ CC-GP41, preserving number: CCTCCNO.V200702.
Below in conjunction with accompanying drawing to recombinant baculovirus AcBac of the present invention △ CCThe construction process of-GP41 is described further.
As shown in Figure 3, recombinant baculovirus AcBac △ CCThe construction process of-GP41 follows these steps to order to carry out:
A, from HIV-1 virus, amplify the gp41 gene with polymerase chain reaction (PCR);
B, the explanation of pressing the pGEM-T Easy of U.S. Promega company support agent box, the gp41 gene order of amplification is cloned on the pGEM-T Easy, blue hickie screening and restriction enzyme EcoRI enzyme through sec.-propyl-B-D thiogalactoside and 5-bromo-4-chloro-3-indoles-β-D-galactoside (IPTG/X-gal) are cut evaluation, acquisition contains gp41 gene plasmid pGEM-T-gp41, and carries out sequence verification and do not have sudden change;
C, utilize the donor plasmid pFastBacHTc of INVITROGEN company, Fig. 1 is the synoptic diagram of pFastBacHTc structure, according to the molecular biology operational manual,, obtain the gp41 of band double digestion cohesive end with restriction enzyme BamHI and XhoI double digestion pGEM-T-gp41;
D, will be cloned on the multiple clone site (MCS) with restriction enzyme BamHI and XhoI double digestion donor plasmid pFastBacHTc with the gp41 of double digestion cohesive end, (6 * His) labels merge frame to make gp41 gene order and 6 Histidines, obtain new donor plasmid pFastBacHTc-gp41, the effect of 6 * His label is to be convenient to Ni-NTA resin affinitive layer purification albumen;
E, according to the Bac-to-Bac of INVITROGEN company baculovirus expression system operational manual, new donor plasmid pFastBacHTc-gp41 be transformed into contain Ac-bac △ CC(number of patent application: in the competent cell of intestinal bacteria DH10B 200710052485.9), by the locus specificity transposition, obtain the chlorampenicol resistant transformant, transformant is cut detection through the PCR detection and the genome enzyme of M13 primer, obtains recombinant shuttle vector Ac-bac △ CC-gp41;
F, according to the transfection of liposome cell transfecting test kit Lipofectin explanation, with containing Grace ' the s substratum of 10% foetal calf serum with 9 * 10 5Insect cell Sf9 or Sf21 cultivated 3 hours in 27 ℃ in the culture dish of 35mm, the Ac-bac that recombinates △ CCThe DNA transfection of-gp41 is cultivated it based on 27 ℃ of cultivations 5~7 days at the Grace ' s that contains 10% foetal calf serum in insect cell Sf9 or Sf21 then, collects the substratum supernatant, and the proteic recombinant baculovirus AcBac of total length GP41 is expressed in contained being in the supernatant △ CC-GP41.Fig. 2 is recombinant baculovirus AcBac △ CCThe synoptic diagram of-GP41 structure.
With the recombinant baculovirus AcBac that obtains among the step f △ CC-Gp41 infected insect cell, collect metainfective insect cell, with the protein expression in the method detection insect cell of SDS-PAGE gel electrophoresis, detected result as shown in Figure 4, obviously the protein band of a visible treaty 41kDa size is consistent with the total length GP41 molecular weight of albumen of expection.Swimming lane shown in the figure contains 3 * 10 approximately 5Insect cell, therefore the proteic expression amount of GP41 is about 2 μ g, extrapolates and utilizes the proteic expression amount of this system expression GP41 can reach 50mg/L.

Claims (2)

1. recombinant baculovirus AcBac Δ CC-GP41 is characterized in that, this recombinant baculovirus AcBac Δ CC-GP41 is: CCTCC NO.V200702.
2. realize the described recombinant baculovirus AcBac of claim 1 Δ CCThe construction process of-GP41 is characterized in that, this construction process follows these steps to order to carry out:
A, from HIV-1 virus, amplify the gp41 gene with polymerase chain reaction PCR;
B, the explanation of pressing the pGEM-T Easy of U.S. Promega company support agent box, the gp41 gene order of amplification is cloned on the pGEM-T Easy, blue hickie screening and restriction enzyme EcoRI enzyme through IPTG/X-gal are cut evaluation, acquisition contains gp41 gene plasmid pGEM-T-gp41, and carries out sequence verification and do not have sudden change;
C, utilize the donor plasmid pFastBacHTc of INVITROGEN company,,, obtain the gp41 of band double digestion cohesive end with restriction enzyme BamHI and XhoI double digestion pGEM-T-gp41 according to the molecular biology operational manual;
D, will be cloned on the multiple clone site MCS with restriction enzyme BamHI and XhoI double digestion donor plasmid pFastBacHTc with the gp41 of double digestion cohesive end, gp41 gene order and 6 Histidine 6 * His labels are merged frame, obtain new donor plasmid pFastBacHTc-gp41;
E, according to the Bac-to-Bac of INVITROGEN company baculovirus expression system operational manual, new donor plasmid pFastBacHTc-gp41 be transformed into contain Ac-bac Δ CCThe competent cell of intestinal bacteria DH10B in, obtain recombinant shuttle vector Ac-bac Δ CC-gp41;
F, according to the transfection of liposome cell transfecting test kit Lipofectin explanation, with Grace ' the s substratum that contains 10% foetal calf serum insect cell Sf9 or Sf21 were cultivated 3 hours in 27 ℃ in culture dish, the Ac-bac that recombinates Δ CCThe DNA transfection of-gp41 is cultivated it based on 27 ℃ of cultivations 5~7 days at the Grace ' s that contains 10% foetal calf serum in insect cell then, collects the substratum supernatant, and the proteic recombinant baculovirus AcBac of total length GP41 is expressed in contained being in the supernatant Δ CC-GP41.
CN2007100526290A 2007-07-03 2007-07-03 Recombined rhabdovirus AcBac delt CC-GP41 and constructing method thereof Expired - Fee Related CN101113460B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007100526290A CN101113460B (en) 2007-07-03 2007-07-03 Recombined rhabdovirus AcBac delt CC-GP41 and constructing method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007100526290A CN101113460B (en) 2007-07-03 2007-07-03 Recombined rhabdovirus AcBac delt CC-GP41 and constructing method thereof

Publications (2)

Publication Number Publication Date
CN101113460A true CN101113460A (en) 2008-01-30
CN101113460B CN101113460B (en) 2011-04-06

Family

ID=39021989

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007100526290A Expired - Fee Related CN101113460B (en) 2007-07-03 2007-07-03 Recombined rhabdovirus AcBac delt CC-GP41 and constructing method thereof

Country Status (1)

Country Link
CN (1) CN101113460B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101358206B (en) * 2008-08-29 2012-08-01 浙江理工大学 Separation method of cellular membrane and cellular organelle membrane protein based on budding of insect virus
CN114317608A (en) * 2020-12-28 2022-04-12 陕西杆粒生物科技有限公司 Gene knockout type baculovirus expression vector

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101358206B (en) * 2008-08-29 2012-08-01 浙江理工大学 Separation method of cellular membrane and cellular organelle membrane protein based on budding of insect virus
CN114317608A (en) * 2020-12-28 2022-04-12 陕西杆粒生物科技有限公司 Gene knockout type baculovirus expression vector
CN114317608B (en) * 2020-12-28 2023-08-22 陕西杆粒生物科技有限公司 Gene knockout type baculovirus expression vector

Also Published As

Publication number Publication date
CN101113460B (en) 2011-04-06

Similar Documents

Publication Publication Date Title
Li et al. Control of expression, glycosylation, and secretion of HIV-1 gp120 by homologous and heterologous signal sequences
US10065994B2 (en) Norovirus derived immunogenic compositions and methods
CN112321688B (en) Stable coronavirus recombinant protein dimer and expression vector thereof
WO1988007082A1 (en) Recombinant baculovirus occlusion bodies in vaccines and biological insecticides
CN113461788B (en) Cat coronavirus recombinant antigen, genetic engineering subunit vaccine thereof and application
EP2654787A1 (en) Modified influenza hemagglutinin proteins and uses thereof
CN110981968B (en) Fusion protein containing rabies virus G protein, preparation method, application and vaccine thereof
CN104292339A (en) Recombinant protein containing SARS virus RBD antigen and baculovirus displaying RBD protein
Tagliamonte et al. HIV-Gag VLPs presenting trimeric HIV-1 gp140 spikes constitutively expressed in stable double transfected insect cell line
CN112175086A (en) Monoclonal antibody of anti-porcine epidemic diarrhea virus nsp13 protein and application
CN101100680B (en) Recombination baculoviral for highly effectively expressing SARS coronavirus S protein and construction thereof
CN102719453B (en) Human papilloma virus 18 L1 (HPV18L1) polynucleotide sequence and its expression vector, host cell and use
CN108210921A (en) A kind of zika virus vaccine and preparation method thereof
CN101113460B (en) Recombined rhabdovirus AcBac delt CC-GP41 and constructing method thereof
Caballero et al. Structural requirements of astrovirus virus-like particles assembled in insect cells
CN114276969A (en) SARS-CoV-2 bacteria-like particle and its application in vaccine
CN105039373A (en) Recombinant plasmid, recombinant virus vector, recombinant virus strain and application thereof, recombinant protein and subunit vaccine containing the same
CN102586287A (en) HPV16L1 polynucleotide sequence and expression vector, host cell and application thereof
CN104292338A (en) Recombinant protein containing SARS virus N antigen and baculovirus displaying N protein
CN104293740A (en) Recombinant baculovirus with surface displaying SARS bivalent antigen, and preparation method and application thereof
CN116063572A (en) Fusion protein for simultaneously expressing BVDV E2 protein and BRSV F protein and bivalent subunit vaccine
CN102363751A (en) Dengue virus (DENV)-like particle as well as preparation method and application thereof
CN104711288A (en) Recombinant vector, recombinant baculovirus prepared from the same and application of virus in preparation of malaria vaccines
CN107513536A (en) A kind of method that HIV 1gp120 are prepared using eukaryotic expression system
CN102321635B (en) Preparation method for human papillomaviral empty capsid particles, and products thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110406

Termination date: 20170703